These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33746168)

  • 1. Primary Biliary Cholangitis-associated Palmar Keratosis.
    Usami J
    Intern Med; 2021 Sep; 60(17):2877. PubMed ID: 33746168
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
    Schattenberg JM
    Gut; 2020 Aug; 69(8):1377-1378. PubMed ID: 32205421
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
    Yuan Z; Jia G; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
    Liu BD; Qureshi K
    Dig Dis Sci; 2023 Feb; 68(2):346-348. PubMed ID: 36098875
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
    Levy C
    Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing Second-Line Treatment for Primary Biliary Cholangitis.
    Assis DN
    N Engl J Med; 2024 Feb; 390(9):853-854. PubMed ID: 38381658
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough?
    Wetten A; Jones DEJ; Dyson JK
    Expert Opin Pharmacother; 2021 Oct; 22(15):1949-1953. PubMed ID: 34121570
    [No Abstract]   [Full Text] [Related]  

  • 8. In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis.
    Lens S
    Gastroenterology; 2024 Aug; 167(3):623-624. PubMed ID: 38387599
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary biliary cholangitis, let's try to keep the new nomenclature correct!
    Harinck F
    Neth J Med; 2016 Jul; 74(6):229-30. PubMed ID: 27571719
    [No Abstract]   [Full Text] [Related]  

  • 10. Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
    Mishra AK; Singh SP
    J Hepatol; 2022 Nov; 77(5):1451. PubMed ID: 35594993
    [No Abstract]   [Full Text] [Related]  

  • 11. [New name and new treatments for primary biliary cholangitits].
    Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
    Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired palmoplantar keratoderma associated with primary biliary cholangitis: Complete and persistent resolution after ursodeoxycholic acid treatment.
    March-Rodriguez A; Marcantonio O; Olmos-Alpiste F; Pujol RM
    Australas J Dermatol; 2022 Feb; 63(1):e49-e51. PubMed ID: 34905624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolving Landscape of Primary Biliary Cholangitis.
    John BV
    Clin Liver Dis; 2022 Nov; 26(4):xiii-xv. PubMed ID: 36270729
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel Treatment Strategies for Primary Biliary Cholangitis.
    Parés A
    Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward precision medicine in primary biliary cholangitis.
    Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF
    Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?
    Gluud C; Christensen E
    J Hepatol; 2001 May; 34(5):787-8. PubMed ID: 11434634
    [No Abstract]   [Full Text] [Related]  

  • 18. Ursodeoxycholic acid for primary biliary cirrhosis.
    Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
    Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease-modifying therapies and symptomatic management for primary biliary cholangitis.
    Patel R; Portone G; Lambert JA; Mak S; Alrubaiy L
    Br J Hosp Med (Lond); 2021 Nov; 82(11):1-9. PubMed ID: 34817254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives.
    Barba Bernal R; Ferrigno B; Medina Morales E; Castro CM; Goyes D; Trivedi H; Patwardhan VR; Bonder A
    Turk J Gastroenterol; 2023 Feb; 34(2):89-100. PubMed ID: 36843300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.